Trials / Completed
CompletedNCT07250295
The Effect of Exercise on Paravertebral Muscle Thickness and Quality of Life in Adolescent Idiopathic Scoliosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Sisli Hamidiye Etfal Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 10 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The study population comprised patients with AIS who had applied to the outpatient clinic between January and June 2022. The patients were divided into two groups. Treatment group(TG) was instructed in specific scoliosis exercises, while the Control group(CG) was given exercises for the lower extremities. Each patient was included in a 12- week exercise program accompanied by a physiotherapist. The patients' quality of life, and paravertebral muscles were evaluated ultrasonographically before and after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise | Patients were expected to attend treatment under the supervision of a physiotherapist. If they missed a day, they were contacted by phone and advised to do their exercises at home. The number of days they missed did not exceed five. Each set included a 30-second rest period to prevent fatigue. A five-minute warm-up and cool-down period was allotted before and after the exercise session. The exercise program was implemented by a physiotherapist with three years of experience in scoliosis management. Before initiating the intervention, the physiotherapist underwent a structured training session, including practical demonstrations, supervised practice, and detailed exercise protocols. |
| OTHER | Exercise for Lower Extremities | The control group (CG) was instructed to perform gluteus maximus, hamstring, and quadriceps strengthening exercises. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2022-06-01
- Completion
- 2022-08-15
- First posted
- 2025-11-26
- Last updated
- 2026-01-09
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07250295. Inclusion in this directory is not an endorsement.